Introduction
Epilepsy surgery is a well-established and successful treatment option for patients with pharmacoresistant structural, i.e. focal symptomatic, epilepsies [1] . Epilepsy surgery, however, is associated with a risk of causing cognitive deterioration [2] . Major determinants of postoperative performance change are (1.) the preoperative cognitive status, i.e. the patients' reserve capacity which can be estimated by baseline performance, education, intelligence, age, and hemisphere dominance, and (2.) the functional importance and contribution of the tissues and fibre tracts to be resected and, connected to this, the preoperative pathological status and the type and extent of the surgical resection [3] . As a third factor seizure control, i.e. recovery from epilepsy after successful surgery has been discussed as a determinant of cognitive outcome. In our previous longitudinal follow-up study in surgically versus medically treated patients with temporal lobe epilepsy we observed longer-term improvements of executive and memory functions, particularly when seizures were successfully controlled (seizure freedom and percentual reduction of seizure frequency) [4] . In our study and in a study by Hermann and Seidenberg dating back to 1995 this improvement was interpreted as the result of a postoperative release of functions secondarily affected by inhibition through epileptic dysfunction before surgery [4, 5] .
An issue which has rarely been explicitly addressed in this context is the effect of the change of the antiepileptic medication from before to after surgery on cognition [6] . It is important to note that in the present evaluation ''change'' is understood as a change of the drug load or change of individual substances and not as postoperative discontinuation of the medication. As for drug withdrawal/discontinuation in seizure free medically treated patients, there is evidence from older and more recent studies that this leads to an improvement of cognitive functions [7] [8] [9] [10] [11] . In addition there are two epilepsy surgery studies which described improvement of intelligence in children after epilepsy surgery, particularly when drugs had been discontinued [12, 13] . Skirrow and colleagues concluded that ''cessation of antiepileptic medication was the strongest predictor of postoperative IQ increase, even after exclusion of patients with continuing seizures, which lends support for the concerns about the potential impact of long-term AED use [. . ..] on cognitive development'' [12] .
With this background, the aim of the present study was to evaluate the effect of antiepileptic drug changes versus seizure control on cognitive outcome in adult patients after epilepsy surgery, particularly on executive functions.
In order to address this question the major selection criterion for the evaluated group of patients who had undergone epilepsy surgery was the pre-and postoperative use of the assessment tool EpiTrack, a brief test of executive functions and working memory, which has been designed and validated for the monitoring AED-induced cognitive side effects [14] [15] [16] . In addition, and as a control condition, we considered changes in memory and mood.
The study explicitly did not aim to evaluate the effects of different types of surgery on cognition. However, since a mixed group of patients was evaluated, and since temporal and extratemporal epilepsies differentially affect memory and executive functions [17] this factor was controlled for in the analysis of the effects of drug changes versus the effects of seizure control.
Methods

Patients
A total of 116 patients was included who had undergone epilepsy surgery with preoperative baseline and one year postoperative follow up evaluation employing both the EpiTrack and standard tests of learning and memory. Most patients also had pre-and postoperative assessment of mood/depression.
Of the 116 patients included, 87 suffered from temporal lobe epilepsy (TLE), and 29 patients from extratemporal lobe epilepsy (ETLE, 20 frontal, 9 posterior).
Gender (49% female), education (56% > 10 years), preoperative IQ (29% between IQ 60 and 85), and side of surgery (54% left) were equally distributed in the patient subgroups. The mean age of the patients was 37.0 AE 12.7 years. Patients with ETLE were younger than those with TLE (F = 9.0, p < 0.01) (see Table 1 ).
Quantitative and qualitative parameters of AED treatment
Antiepileptic treatment was assessed by consideration of the number of concurrent antiepileptic drugs before and after surgery, as well as by the pre-and postoperative total drug load based on the defined daily dose (DDD). DDD was calculated according to the ATC index of the WHO Collaborating Centre for Drug Statistics Methodology (WHOCC) reported for the drugs in use (www.whocc. no\ddd\definition_and_general_considera/). For polytherapy, DDD of the individual concurrent drugs were summed up. As recently demonstrated, both measures of drug load show a good correlation to EpiTrack performance [18] .
In addition, for each drug, withdrawal and new introduction were listed in order to have qualitative information about which drugs had been changed apart from simply calculating numbers of AED or DDD total drug load.
Neuropsychological assessment
The diagnostic measures of interest were executive functions, learning and memory, as well as mood which had been assessed before surgery (baseline T1), and again at a standard postoperative retest-interval of 12 months (follow-up T2). For executive functions and memory parallel test versions were applied before and after surgery. It is important to note that neuropsychological baseline evaluation before surgery is always performed under stable treatment conditions, i.e. when patients enter the clinic and before any change of medication is being made.
Executive function
EpiTrack 1 (second adult edition with recently extended and revised norms) is a screening tool which had explicitly been designed for tracking adverse cognitive effects of antiepileptic medication [19] . The test includes six subtests addressing response inhibition, visuo-motor speed, mental flexibility, visuo-motor planning, verbal fluency, and working memory. Based on the subtest results, an agecorrected total score is calculated. Age-corrected norms from 689 healthy individuals (age range 16-87 years) are available. Higher scores reflect better performance with a maximum score of 49 points. A score in the range of 29-31 points indicates mild impairment, the cut-off for severe impairment is 28 points.
For test repetition and interpretation of individually significant change, practice-corrected reliable change indices (RCI) are available (p = 0.1).
From a neuropsychological point of view and apart from its sensitivity to AED, the EpiTrack, with its strong focus on executive functions and working memory, may well be considered as a screening test for frontal lobe functions.
Memory function
Verbal and nonverbal capacities in episodic memory were assessed in 112 of the 116 patients by use of the Verbal Learning and Memory Test (VLMT, a German adaptation of the Rey Verbal Learning Test [20] ) and the Diagnosticum fü r Cerebralschä digung, revised version (DCS-R), a design learning test [21] . The VLMT includes word list learning (15 words) with immediate free recall in 5 learning trials, free recall after distraction, delayed free recall, and recognition; the DCS-R requires design learning (9 designs) followed by immediate recall in 5 leaning trials, and delayed recognition.
Both tests have been successfully used in several studies of cognitive effects of epilepsy surgery and of temporal lobe surgery on memory in particular and can be considered as predominantly reflecting temporal lobe memory function (for overview see [3] .
To condense information in regard to the many memory parameters which can be extracted from the two memory test, the one test parameter was selected from each test, which is most representative for total test performance (verbal: memory/remembered words in delayed free recall, figural: immediate recall after the last learning trial). The two test parameters were age-corrected, transformed into standard values (m = 100, SD = 10) according to normative data from 488 healthy subjects, and merged into a total memory score ((standardized verbal memory performance + standardized figural memory performance)/2). This total memory score was considered as representative for the memory domain.
Similar to the EpiTrack 1 practice-corrected RCI are available for the total memory score so that significant change can be determined on an individual basis (p < 0.1).
Moreover, since the 488 healthy subjects of the normative sample were also included in the EpiTrack norms, the three tests can be considered as co-normalized, at least to a large extent. A subsample (n = 100) underwent repeated testing after 6 months for determination of test-retest reliability and practice effects.
Mood
Mood was assessed in 85 of the 116 patients by use of the Beck Depression Inventory (BDI-I). The BDI is a reliable and valid self-rating questionnaire for the assessment of depressive symptoms consisting of a 21-item scale with four severity ratings for each item [22] . Concerning the measurement of depression in epilepsy the BDI total score shows a fairly high sensitivity and good specificity [23, 24] . The clinical cut-off for depressed mood was !11 points. For the BDI no RCI were at hand. Therefore categorical change from the impaired into the unimpaired category and vice versa were rated as individual change.
Statistics
For report of the preoperative status descriptive statistics as well as analyses of variance (ANOVA) were performed.
The heart of the analysis were repeated measures analysis of covariance (ANCOVA), separate for executive functions, memory, and mood, with performance/behavioral changes from before to after surgery as within-subject factor, site of surgery (temporal/ extratemporal) and seizure control (seizure free yes/no) as between-subject factors, and change of daily drug dose as covariate.
Partial correlations were calculated in order to control the correlation between drug change and performance change for the impact of seizure control and the correlation between seizure control and performance change for the impact of drug change, respectively.
All statistics were calculated by use of IBM SPSS Statistics 22.
Ethics statement
The evaluation was part of the Transregio SFB TR3 A1 and A10 which were approved by the ethics committee of the University of Bonn Medical Center. All patients gave informed consent. The data sets were acquired prospectively and subsequently anonymized for further analyses.
Results
Seizure outcome
At baseline patients as a total experienced 19.2 AE 47.0 seizures/ month (simple partial + complex partial + generalized tonic-clonic seizures). ETLE patients had a higher monthly seizure rate than TLE patients at this time (F = 20.7, p < 0.001).
After surgery the seizure rate dropped significantly to 1.2 AE 3.7 seizures/month (t = 3.9, p < 0.001). On an individual level, 65% of the entire sample achieved complete seizure freedom (Engel Ia). Percent seizure control, and the number of patients who achieved complete seizure freedom did not differ between the groups (see Table 1 ).
Drug treatment changes
At baseline patients were taking a mean of 2.4 AE 0.8 different AEDs, at follow up, they were taking 2.1 AE 0.6. (t = 3.72, p < 0.001). Total DDD dropped as a trend (t = 1.9, p = 0.06). Patients with ETLE took more antiepileptic drugs at baseline (F = 9.1, p < 0.01) and had more drugs withdrawn after surgery (F = 21.9, p < 0.001) than patients in the TLE group. There was, however, only a non-significant group trend of a difference between TLE and ETLE in terms of the total DDD at T1 and its change seen after surgery (F = 3.6, p = 0.058, F = 2.9, p = 0.09) (see Table 1 ).
Less than 10% of the patients were on antidepressants before surgery. After surgery antidepressants were more often newly introduced than withdrawn (chi2 = 6.3 df 1 p < 0.05). Still, at T2, only a minority of 14% of patients was treated with antidepressants. Table 2 displays the qualitative AED changes. The most commonly withdrawn drugs were carbamazepine (CBZ), clobazam (CLB), oxcarbazepine (OXC), zonisamide (ZNS) and also phenytoin (PHT), although the latter had only been used infrequently before surgery. Newly introduced drugs mainly comprised lamotrigine (LTG) and levetiracetam (LEV). Therefore, the drug regimen did not only change quantitatively but also qualitatively since, as a trend, AED with potentially more adverse effects had been replaced by drugs with more favorable side effect profiles (see Table 2 ).
Changes in cognition and mood
At baseline (T1), 60% of all patients showed deficits in executive functions (EpiTrack) as compared to 54% who showed memory problems (VLMT & DCS-R combined). Mood problems were indicated in 49% of the evaluated patients (Table 3) .
Whereas in regard to executive functions, patients with ETLE showed poorer performance than patients with TLE (F = 7.4, p < 0.01), there was no significant difference between the groups in regard to memory or mood.
The group difference revealed by inference statistics was confirmed by individual level analyses according to which 79% of patients with ETLE had impaired executive functions as compared to 54% of the TLE group (chi 2 = 9.7, p < 0.01). Memory was impaired in 56% in TLE and in 48% in ETLE.
In terms of performance changes between T1 and T2, executive functions and mood significantly improved in the total group (t = 2.3 and À2.6 with p < 0.05 and 0.01), but there were no significantly different changes when comparing the patient subgroups. Memory, however, declined significantly in patients with temporal lobe resections (t = À3.0, p < 0.01). Individual level analysis indicated gains in executive functions, memory and mood in 22%, 10%, and 32% of the patients, respectively, and losses in 15%, 21%, and 11% (Table 3) .
Impact of surgery, seizure control, and AED changes on cognitive outcome
Repeated measures ANCOVA with executive functions and memory at T1 and T2 as within-subject factors, with site of surgery and seizure control as between-subject factors, and with change in the total DDD as covariate, revealed a significant interaction effect of test-retest by drug dose difference (F = 9.3, p < 0.001), and a # preoperative = impaired, pre-to postoperative = significant deterioration according to RCI. " pre-to postoperative = significant improvement according to RCI. * p < 0.05. ** p < 0.01.
n.s. not significant.
significant interaction effect of test-retest by site of surgery (F = 4.9, p = 0.009) on cognition. According to univariate tests, the first interaction effect was particularly due to a significant improvement of executive functions with reduced total DDD (F = 17.8, p < 0.001) (see Fig. 1a ). For memory only a nonsignificant trend of improved performance with drug load reduction was found (F = 3.1, p = 0.08). The second interaction effect was due to a deterioration of memory after temporal lobe surgery (F = 9.6, p = 0.002) (see Fig. 1b ). Repeated measures MANCOVA of the BDI revealed no significant results.
Individual changes in executive functions as a function of drug change (difference score: postoperative minus preoperative performance) indicated more frequent significant gains in patients in whom AEDs had been withdrawn and more significant losses in those with unchanged or additional AEDs (chi 2 = 12.6 df 6, p = 0.049) (Fig. 2) . The same analysis, with seizure control as the independent variable, showed that losses in executive functions were more frequent in those who did not became seizure free (chi 2 = 6.6 df 2, p = 0.037) (Fig. 2) .
Individual change in total memory as a function of site of surgery confirmed more frequent losses (22%) than gains (5%) after temporal lobe resections, whereas after extratemporal lobe surgery gains (25%) were more frequent than losses (17%).
As already mentioned there were quantitative as well as qualitative changes of the drug regimen from before to after surgery. The withdrawal of the drugs clobazam (CLB), zonisamide (ZNS), topiramate (TPM), phenytoin (PHT), or phenobarbital (PB) in particular correlated significantly with improvements in memory (r = À0.24, p = 0.01, n = 112) and mood (r = 0.22, p = 0.04, n = 85), but less so with change in executive functions (r = À0.17, p = 0.07, n = 116).
Antiepileptic drug changes from before to after surgery cannot be treated separately from seizure outcome. Therefore, it was necessary to evaluate the relative contribution of both factors to improvement in executive function.
With a correlation coefficient of r = 0.38 change in EpiTrack performance correlated quite well with change of total DDD (Fig. 3) .
Statistically controlling this correlation for seizure control changed the correlation to r partial = 0.28 (each p < 0.001), but it remained still highly significant. The correlation between seizure control and EpiTrack changed from r = 0.21 (p = 0.02) to r partial = 0.13 (p = 0.08) when controlling for changes in total DDD and thereby lost significance. Similar to executive functions, memory change correlated with total DDD change (r = 0.19, p = 0.048), whereas memory change and seizure control did not (r = 0.064, p = 0.50). The correlation of the total DDD with postoperative memory change lost some significance when we controlled for seizure outcome (r partial = 0.18, p = 0.057). Comparably, the correlation of seizure control with memory change became worse when controlling for drug load change (r partial = 0.04, p = 0.65). 
Discussion
Epilepsy surgery is a well-established and often successful treatment option for patients with pharmacoresistant epilepsies. However, it is associated with the risk of causing additional cognitive impairments to any pre-existing deficits [2] . Postoperative improvement or recovery of cognition has been described as well and, as described in the introduction, has usually been attributed to seizure control and the release of cognition due to the cessation of interictal epileptic dysfunction. Against this background the present study evaluated the role of changes of the AED regimen from before to after temporal and extratemporal lobe epilepsy surgery versus seizure control in relation to postoperative improvement in executive functions, memory, and mood.
At baseline, patients with ETLE showed poorer executive functions than those with TLE. This would be as expected in a group of ETLE patients mainly consisting of patients with frontal lobe epilepsy [25, 26] . The prevalence of memory deficits was only slightly higher in patients with TLE than in ETLE. That memory can be impaired in TLE and ETLE as well has been described before [27] .
The comparison of the pre-and postoperative drug regimens shows that drug treatment had been changed quantitatively and qualitatively. Patients took significantly less AEDs after surgery and the drug load in terms of the total DDD dropped accordingly. Although this may be center-specific, patients were also converted to drugs with more favorable cognitive side effect profiles (LEV and LTG) [18] . Drug dose reduction and qualitative drug changes were not significantly different in patients who were seizure free postoperatively and those who were not. The reason for this is that, in our clinic, the drug regimen is changed and optimized before surgery and after drugs have been withdrawn as part of the presurgical work up. Neuropsychological testing is regularly performed before any of these medication changes when the patient enters the clinic. Then AED are withdrawn with the purpose of seizure provocation. After the presurgical work up and before surgery is performed, the patients take the reduced medication they are meant to continue to take immediately after surgery. This procedure leaves the physician with more options after surgery.
In terms of the cognition/mood change observed after surgery the results indicate different outcomes depending on change of AED treatment, seizure control, and site of surgery. This could be demonstrated at group and individual level.
Independent of the site of surgery, reduction of AED, i.e. the reduction of the total number of AED, and even more strongly, the reduction of the total DDD were associated with improvements in executive functions after surgery (see Fig. 1a, Figs. 2 and 3 ). Seizure control only had a mild effect on the postsurgical outcome in executive functions and memory. The small effect lost statistical significance when controlling for AED changes. On an individual level half (56%) of the 41 patients in whom at least one drug was withdrawn significantly improved in executive functions as defined by practice-corrected RCI. In contrast 22% of the 15 patients in whom one drug was added worsened (Fig. 2) .
The results thus confirm previous research demonstrating that executive functions in particular are sensitive to drug load and the presence/absence of individual antiepileptic drugs with particularly adverse effects on cognition [28] . In concordance with this, improvements with drug discontinuation were mainly observed in terms of executive functions. This finding is in line with those of previous withdrawal studies mentioned in the introduction [7] [8] [9] [10] [11] . In addition our findings confirm the usefulness of the cognitive screening tool ''EpiTrack 1 '', which takes 12-15 min test time and which represents the synthesis (or rather the condensation) of neuropsychological test parameters which best covaried with antiepileptic drug treatment in patients who had undergone extensive testing in the context of presurgical evaluations [15] .
Memory was the second cognitive outcome parameter, chosen to control for the specificity of drug load effects on executive functions. According to previous overviews, learning and memory seem less vulnerable to AED than working memory or executive functions [16, 29, 30] . Learning and memory in contrast are highly vulnerable to temporal lobe pathology and surgery [2, 31] .
Consistent with this, for memory only a non-significant trend of improved performance with drug load reduction was found (F = 3.1, p = 0.08). Here one must take into consideration that memory performance may be affected directly by drug withdrawal but since most memory tests have a strong executive component also indirectly via the improvement of the executive functions [32] . As one would expect from the literature, memory declined after temporal lobe surgery [3] and tended to become better after extratemporal (mostly frontal lobe) surgery [33] (see Fig. 1b) . When practice-corrected RCI were considered, patients with TLE declined in memory (22%) more often than that they showed gains (5%). In the ETLE group gains (25%) were more frequent than losses (17%), but this difference was not significant. Interestingly, qualitative rather than quantitative drug changes had an impact on memory outcome, i.e. memory improved with withdrawal of drugs with less favorable and introduction of or conversion to drugs with more favorable cognitive side effect profiles, The third outcome parameter was mood. Mood problems represent the most frequent psychiatric comorbidity in epilepsy [34] . After surgery mood may change positively or negatively and AED treatment can contribute to this [35] . The data presented here indicate quite nonspecific improvements, i.e. site of surgery or seizure outcome had no differential effect on mood change. In about 30% of the patients mood improved, and it worsened in 10%. Correlation statistics indicated that, as observed with memory, qualitative drug changes rather than quantitative drug changes were related to improvement in this domain.
The central question of this study was the differential effect of AED changes versus seizure control on postoperative cognitive outcome. In this regard partial correlations complete the picture from group and individual level analyses and support the notion that changes of the AED drug load explain performance changes in executive functions better than improvements in seizure control. Accordingly, one should not attribute postoperative cognitive improvements to seizure control alone. An important question for the future will be whether the effects observed with postoperative drug reductions will be even greater in those patients in whom AEDs can be withdrawn completely [12, 13] .
In conclusion the findings provide evidence that reduction of antiepileptic drug load and the choice of drugs with favorable side effect profiles can lead to cognitive improvement particularly of executive functions, attention and working memory, thereby supporting cognitive recovery after epilepsy surgery.
Conflict of interest statement
Prof. Dr. Helmstaedter reports license fees for EpiTrack, and personal fees from UCB, Eisai, ViaMed GmbH, and Elsevier, and grants from E-pilepsy EU project EAHC outside the submitted work.
Dr. Elger reports personal fees from Bial, personal fees from Cyberonics, personal fees from Desitin, personal fees from Eisai, personal fees from Novartis, personal fees from Pfizer, personal fees from UCB, outside the submitted work.
Dr. Witt reports personal fees from Eisai and UCB, outside the submitted work.
